LANCRIX

Zonisamide, ≥98%

Catalog No. 556740

Identification
SynonymsAD 810, CI 912
CAS No.68291-97-4
M.F.

C8H8N2O3S

M.W.212.23
Technical Data
AppearanceWhite to light yellow crystalline powder
Assay≥98%
SolubilityDMSO, Water
Storage2-8℃
ApplicationZonisamide is a sulfonamide antiseizure agent approved for use as an adjunctive therapy in adults with partial-onset seizures for adults. It has been shown to block voltage-sensitive T-type Ca2+ and Na+ channels, and stimulate BKCa channels. It has also been shown to modulate glutamate, monoamine, and GABA neurotransmission. It is reported to scavenge nitric oxide and hydroxyl free radicals, and inhibit lipid peroxidation. It exhibits antiParkinsonian and neuroprotective activity.
Safety Data
Reference

Huang CW, et al. J Pharmacol Exp Ther. 2007;321(1):98-106
Gluck MR, et al. J Neural Transm. 2004;111(6):713-24
Sobieszek G, et al. Pol J Pharmacol. 2003;55(5):683-9
Tokumaru J, et al. Neurochem Res. 2000;25(8):1107-11

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 556740, Zonisamide, ≥98%, 68291-97-4
*Message
*Code If it’s not clear, please click on the picture to change one.